{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:04:02Z","timestamp":1756461842237,"version":"3.41.2"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Here, we report the case of an infant suffering from Alagille syndrome (ALGS), manifesting with the atypical clinical manifestations of prenatal oligohydramnios and renal lesions. To the best of our knowledge, this is the first case of ALGS presenting as prenatal oligohydramnios and renal lesions caused by a <jats:italic>de novo<\/jats:italic> variant of the <jats:italic>NOTCH<\/jats:italic>2 gene.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>A 3-month-old male infant was hospitalized for severe malnutrition. He presented with prenatal oligohydramnios from 28<jats:sup>+4<\/jats:sup> weeks of gestation. After birth, he failed to thrive and suffered from impaired motor development, thermoregulation disorders, congenital bilateral renal hypodysplasia, which initially manifested as stage 5 before improving to stage 3 chronic renal impairment, slightly elevated levels of transaminases, cholestasis, and dysmorphic facial features. We used a diagnostic screening panel of 4,047 pathogenic genes and whole exome sequencing (WES) to analyze the proband and his parents (who had normal kidneys). We found that the proband carried a <jats:italic>de novo<\/jats:italic> heterozygous splicing variant (c.5930-2A\u2009&amp;gt;\u2009G) in intron 33 of the <jats:italic>NOTCH<\/jats:italic>2 gene. Transcriptome sequencing confirmed that the mutation of this gene site would affect the splicing of NOTCH2 mRNA and lead to exon 33 skipping.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our case expands the spectrum of pathogenic variants of the <jats:italic>NOTCH<\/jats:italic>2 gene that are known to be associated with ALGS and characterized by prenatal oligohydramnios and renal lesions. It also reminds us of the necessity to monitor the liver and kidney function of the infant if a mother has oligohydramnios during pregnancy and we recommend ALGS as an additional differential diagnosis in prenatal renal abnormalities.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2022.1020536","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T07:25:40Z","timestamp":1668497140000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Alagille syndrome due to a de novo NOTCH2 mutation presenting as prenatal oligohydramnios and congenital bilateral renal hypodysplasia: A case report"],"prefix":"10.3389","volume":"10","author":[{"given":"Fengdan","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoguang","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuanglan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1055\/s-0041-1730951","article-title":"Alagille syndrome: a focused review on clinical features, genetics, and treatment","volume":"41","author":"Kohut","year":"2021","journal-title":"Semin Liver Dis"},{"key":"B2","first-page":"51","article-title":"Surgical attempts in atresia of the intrahepatic bile ducts with permeable extrahepatic bile duct. Study of 14 cases in children","volume":"26","author":"Alagille","year":"1969","journal-title":"Arch Fr Pediatr"},{"key":"B3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0022-3476(75)80706-2","article-title":"Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental, and sexual development, and cardiac murmur","volume":"86","author":"Alagille","year":"1975","journal-title":"J Pediatr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.cld.2018.06.001","article-title":"Alagille syndrome","volume":"22","author":"Mitchell","year":"2018","journal-title":"Clin Liver Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cld.2022.03.002","article-title":"Alagille syndrome: Current understanding of pathogenesis, and challenges in diagnosis and management","volume":"26","author":"Ayoub","year":"2022","journal-title":"Clin Liver Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1002\/humu.23879","article-title":"Alagille syndrome mutation update: comprehensive overview of JAG1 and NOTCH2 mutation frequencies and insight into missense variant classification","volume":"40","author":"Gilbert","year":"2019","journal-title":"Hum Mut"},{"key":"B7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.5005\/jp-journals-10018-1280","article-title":"Alagille syndrome and the liver: current insights","volume":"8","author":"Singh","year":"2018","journal-title":"Euroasian J Hepatogastroenterol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1891\/0730-0832.36.6.343","article-title":"Alagille syndrome: an overview","volume":"36","author":"Jesina","year":"2017","journal-title":"Neonatal Netw"},{"key":"B9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1167\/iovs.62.7.27","article-title":"Characterization of the spectrum of ophthalmic changes in patients with Alagille syndrome","volume":"62","author":"da Palma","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1242\/dev.129.4.1075","article-title":"A mouse model of Alagille syndrome: NOTCH2 as a genetic modifier of Jag1 haploinsufficiency","volume":"129","author":"McCright","year":"2002","journal-title":"Development"},{"key":"B11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1086\/505332","article-title":"NOTCH2 Mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway","volume":"79","author":"McDaniell","year":"2006","journal-title":"Am J Hum Genet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.cca.2021.07.026","article-title":"Alagille syndrome caused by NOTCH2 mutation presented atypical pathological changes","volume":"521","author":"ShenTu","year":"2021","journal-title":"Clin Chim Acta"},{"key":"B13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.5546\/aap.2018.eng.149","article-title":"Renal manifestations in children with Alagille syndrome","volume":"116","author":"Di Pinto","year":"2018","journal-title":"Arch Argent Pediatr"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1016\/j.jpedsurg.2019.04.022","article-title":"Outcomes of liver transplantation for Alagille syndrome after Kasai portoenterostomy: Alagille syndrome with agenesis of extrahepatic bile ducts at porta hepatis","volume":"54","author":"Gunadi","year":"2019","journal-title":"J Pediatr Surg"},{"key":"B15","doi-asserted-by":"publisher","first-page":"704586","DOI":"10.3389\/fphar.2021.704586","article-title":"Therapeutics development for Alagille syndrome","volume":"12","author":"Sanchez","year":"2021","journal-title":"Front Pharmacol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/S0140-6736(21)01256-3","article-title":"Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study","volume":"398","author":"Gonzales","year":"2021","journal-title":"Lancet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2147\/JMDH.S295441","article-title":"Multidisciplinary management of Alagille syndrome","volume":"15","author":"Menon","year":"2022","journal-title":"J Multidiscip Healthcare"},{"key":"B18","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/hep.510290331","article-title":"Features of Alagille syndrome in 92 patients: frequency and relation to prognosis","volume":"29","author":"Emerick","year":"1999","journal-title":"Hepatol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.1020536\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T07:25:42Z","timestamp":1668497142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.1020536\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,15]]},"references-count":18,"alternative-id":["10.3389\/fped.2022.1020536"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.1020536","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2022,11,15]]},"article-number":"1020536"}}